Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02906293 · ClinicalTrials.gov registry record
AbStats: Assessing Post-Prandial Intestinal Event Rates in Healthy Individuals
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT02906293: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT02906293 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02906293 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study seeks to: Assess "normal" intestinal event rates for healthy subjects, to determine the effect of meal size on an individual's intestinal rate, and to determine whether there are differences between individuals in the fasting and post-prandial setting. The investigators hypothesize the following: 1. Fasting intestinal rate will be consistently less than 14 events per minute, similar to previously documented bowel sound frequency. 2. There will a uniform increase in intestinal rate in the immediate post-prandial setting. There will be direct correlation between maximal and average post-prandial intestinal rates and meal size. Likewise, meal size will correlate with time to baseline fasting intestinal rate. 3. Males and those with lower body mass index (BMI) will experience higher maximal and average post-prandial intestinal rates and shorter time to baseline fasting levels compared to females and those with higher BMI, respectively.
Primary Outcome
Prior to any oral intake, participants will record intestinal rate for 10 minutes
Interventions
- OTHER Abdominal acoustic measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2017-07-17 |
What the finished NCT02906293 record still lists
NCT02906293 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Abdominal acoustic measurement is the first listed.
NCT02906293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02906293 about?
NCT02906293 is a clinical study titled "AbStats: Assessing Post-Prandial Intestinal Event Rates in Healthy Individuals". This study seeks to: Assess "normal" intestinal event rates for healthy subjects, to determine the effect of meal size on an individual's intestinal rate, and to determine whether there are differences between individuals in the fasting and post-prandial setting. The investigators hypothesize the f...
What is the current status of trial NCT02906293?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2017-03-01. Estimated completion is 2017-07-17.
What interventions are being tested in trial NCT02906293?
The interventions under investigation include: Abdominal acoustic measurement (OTHER).
Who is sponsoring clinical trial NCT02906293?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI